Matthew Hegreness is an associate in the firm’s Washington, DC office, specializing in the regulation of food, pharmaceuticals, dietary supplements, and cosmetics. He counsels clients on compliance with state and federal regulatory regimes, especially those of the Food and Drug Administration and Federal Trade Commission. Dr. Hegreness also provides advice and regulatory due diligence to support the corporate transactions and securities filings of the firm’s life sciences clients. Dr. Hegreness’s legal counsel reflects a strong grasp of underlying scientific issues, developed during his years as a research biologist.
Dr. Hegreness graduated from Yale Law School, where he was the editor-in-chief of the Yale Journal of Health Policy, Law, and Ethics. The Yale faculty awarded him three prizes for his scholarship, including a prize for the best student contribution to the Yale Law Journal. Prior to law school, Dr. Hegreness was a research scientist at Harvard Medical School, where he studied drug interactions, antibiotic resistance, and the evolution of cancer. His research articles have been published in some of the world’s top scientific journals, including Science, Nature Genetics, and the Proceedings of the National Academy of Sciences. These articles have been cited hundreds of times in subsequent peer-reviewed publications.